Results 181-200 of 1,490 for drugs speaker:Stephen Donnelly

Written Answers — Department of Health: Cannabis for Medicinal Use (11 Jul 2023)

Stephen Donnelly: In Statutory Instrument 262/2019 The Misuse of Drugs (Prescription and Control of Supply of Cannabis for Medical Use) Regulations 2019 the definition of “specified controlled drugs” as used in the programme specifies that is a product (d) which is permitted to be sold or supplied for medical purposes by the relevant public or state body of a Member State other than the State, ...

Written Answers — Department of Health: Medicinal Products (11 Jul 2023)

Stephen Donnelly: As the Health Service Executive (HSE) are conducting a review of the access provided to Cariban under the community drug schemes since 1st January 2023, this matter has been referred to the HSE for direct reply to the Deputy.

Written Answers — Department of Health: State Bodies (6 Jul 2023)

Stephen Donnelly: The NCPE was subject to audit in 2019 as part of a review commissioned by the Department of Health and conducted by Mazars examining the governance arrangements to support the HSE’s drug reimbursement process. In relation to staffing and governance the report highlighted that: “As their roles are so specialist, we reviewed the qualifications of the staff at the NCPE. We noted...

Written Answers — Department of Health: Medical Cards (4 Jul 2023)

Stephen Donnelly: The Health Service Executive (HSE) has statutory responsibility for decisions on pricing and reimbursement of medicines under the Community Drug Schemes, in accordance with the provisions of the Health (Pricing and Supply of Medical Goods) Act 2013. Reimbursement is for licensed indications which have been granted market authorisation by the European Medicines Agency (EMA) or the Health...

Written Answers — Department of Health: Health Services (4 Jul 2023)

Stephen Donnelly: The Health Service Executive (HSE) has statutory responsibility for decisions on pricing and reimbursement under the community drug schemes, in accordance with the provisions of the Health (Pricing and Supply of Medical Goods) Act 2013. I, as the Minister for Health, have no role in these decisions. The HSE have advised that Platelet rich plasma (PRP) injections, or any other blood...

Written Answers — Department of Health: Medicinal Products (29 Jun 2023)

Stephen Donnelly: I propose to take Questions Nos. 422 and 423 together. The Health Service Executive (HSE) has statutory responsibility for medicine reimbursement decisions under the community drugs schemes, in accordance with the Health (Pricing and Supply of Medical Goods) Act 2013. Budget 2023 provided funding of €1.3m to allow reimbursement support for Cariban® (doxylamine/pyridoxine), for...

Written Answers — Department of Health: Departmental Schemes (27 Jun 2023)

Stephen Donnelly: ...; diabetes mellitus; parkinsonism; epilepsy; phenylketonuria; haemophilia; spina bifida; hydrocephalus; and conditions arising from the use of Thalidomide. Under the LTI Scheme, patients receive drugs, medicines, and medical and surgical appliances directly related to the treatment of their illness, free of charge. The Health Service Executive (HSE) administer the LTI Scheme on behalf of...

Written Answers — Department of Health: Medicinal Products (27 Jun 2023)

Stephen Donnelly: ...personBed and boardBasic aids and appliances necessary to assist a person with the activities of daily livingLaundry serviceA person's eligibility for other schemes, such as the medical card scheme or the drugs payment scheme, is unaffected by participation in the NHSS and for this reason, medications and aids that are already prescribed for individuals under an existing scheme are not...

Written Answers — Department of Health: Departmental Budgets (22 Jun 2023)

Stephen Donnelly: ...to contact myself or the Department 2016 Proposed Savings identified €125m Description of Area of Saving : €15m in the procurement process and €110m targeted reduction in prescribing and drug costs within PCRS 2017 Proposed Savings identifiednil Description of Area of Saving : not applicable 2018 Proposed Savings identified €346m Description of Area of Saving...

Written Answers — Department of Health: Medical Cards (22 Jun 2023)

Stephen Donnelly: ...in the country, i.e. full eligibility (medical card holders) and limited eligibility (all others). Adults with full eligibility can access a range of services including GP services, prescribed drugs and medicines, public in-patient hospital services, including consultants’ services, all out-patient public hospital services including consultants’ services, dental, ophthalmic...

Written Answers — Department of Health: Medicinal Products (22 Jun 2023)

Stephen Donnelly: ...in Ireland is the Health Products Regulatory Authority (HPRA). The remit and regulatory functions of the HPRA include human and veterinary medicines, clinical trials, medical devices, controlled drugs, blood and blood components, tissues and cells, and cosmetic products. The Department of maintains regular contact with the HPRA regarding medicines shortages. Ireland has a...

Written Answers — Department of Health: Medicinal Products (22 Jun 2023)

Stephen Donnelly: The Health Service Executive (HSE) has statutory responsibility for decisions on pricing and reimbursement of medicines under the Community Drug Schemes, in accordance with the provisions of the Health (Pricing and Supply of Medical Goods) Act 2013. Reimbursement is for licensed indications which have been granted market authorisation by the European Medicines Agency (EMA) or the Health...

Written Answers — Department of Health: Medicinal Products (21 Jun 2023)

Stephen Donnelly: The Health Service Executive (HSE) has statutory responsibility for decisions on pricing and reimbursement of medicines under the community drugs schemes, in accordance with the Health (Pricing and Supply of Medical Goods) Act 2013. Reimbursement for medicines under the community drugs schemes is for licensed indications which have been granted market authorisation by the European Medicines...

Written Answers — Department of Health: Departmental Data (21 Jun 2023)

Stephen Donnelly: ...must be reviewed every third year after 2020. My Department is currently carrying out a review. Data in respect of the number of items dispensed by community pharmacists under the community drug schemes is available on the Primary Care Reimbursement Service (PCRS) website at the following link: www.sspcrs.ie/portal/annual-reporting/report/pharmacy This data includes the year 2022 and is...

Written Answers — Department of Health: Pharmacy Services (20 Jun 2023)

Stephen Donnelly: ...to Community Pharmacy Contractors) Regulations 2019 – S.I. 639 of 2019 – which came into effect from 1 January 2020. Since then, the overall spend on fees paid to community pharmacists under the community drug schemes has continued to rise year-on-year. The Primary Care Reimbursement Service (PCRS) online system shows fees paid to pharmacies under the community drug schemes...

Written Answers — Department of Health: Health Service Executive (20 Jun 2023)

Stephen Donnelly: ...for the advancement of the discipline of pharmacoeconomics through practice, research and education. The NCPE is an independent Health Technology Assessment (HTA) Agency responsible for evaluating drug treatments for use in the Irish healthcare setting. The NCPE conducts the HTA of drugs for the health service in Ireland in collaboration with the Health Service Executive's Corporate...

Written Answers — Department of Health: Medicinal Products (20 Jun 2023)

Stephen Donnelly: The Drug Payment Scheme (DPS) provides for the refund of the amount by which expenditure on approved prescribed medicines or medical and surgical appliances exceeds a named threshold in any calendar month. The DPS is not means tested and is available to anyone ordinarily resident in Ireland. The DPS threshold was reduced twice in 2022: From €114 to €100 per month on 1 January...

Written Answers — Department of Health: Medicinal Products (20 Jun 2023)

Stephen Donnelly: The Health Service Executive (HSE) has statutory responsibility for decisions on pricing and reimbursement of medicines under the community drugs schemes, in accordance with the Health (Pricing and Supply of Medical Goods) Act 2013. HSE decisions on which medicines are reimbursed by the taxpayer are made on objective, scientific and economic grounds, on the advice of the National Centre for...

Written Answers — Department of Health: Health Services Staff (20 Jun 2023)

Stephen Donnelly: ...for the advancement of the discipline of pharmacoeconomics through practice, research and education. The NCPE is an independent Health Technology Assessment (HTA) Agency responsible for evaluating drug treatments for use in the Irish healthcare setting. The NCPE conducts the HTA of drugs for the health service in Ireland in collaboration with the Health Service Executive's Corporate...

Written Answers — Department of Health: Medicinal Products (20 Jun 2023)

Stephen Donnelly: The Health Service Executive (HSE) has statutory responsibility for decisions on pricing and reimbursement of medicines under the community drugs schemes, in accordance with the Health (Pricing and Supply of Medical Goods) Act 2013. HSE decisions on which medicines are reimbursed by the taxpayer are made on objective, scientific and economic grounds, on the advice of the National Centre for...